Friday, August 15, 2014 6:29:49 PM
It is a biologic. Period
The BLA is a similar process for biologics and as the NDA process is for drugs which are synthetic and manufactured.
My point again
However, an autologous stem cell phase 3 trial as in the case of Myocell doesn't require as many enrollments as say a new drug as Myocell is from your own body.
This all started as I was trying to explain the major cost difference
Of having thousands of patients versus a few hundred.
Drug or allogeneic stem cells require more.
Therefore phase 3 trials will cost less for Bioheart.
The approval process will be just as stringent as a drug.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM